%0 Journal Article
%T Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life
%A Giuseppe Cicero
%A Giuseppe Profita
%A Rossella De Luca
%J Archive of "OncoTargets and therapy".
%D 2019
%R 10.2147/OTT.S191519
%X Metastatic breast cancer (MBC) is an incurable disease; the treatment of this disease prolongs survival, improving the quality of life (QoL) with a balance between efficacy and toxicity of the treatment. In recent years, treatment with nab-paclitaxel has improved the already known antitumor activity of conventional paclitaxel, in terms of increased efficacy and better tolerability. The aim of this study was to evaluate nab-paclitaxel in Italian patients with MBC
%K Abraxane£¿
%K breast cancer metastasis
%K Ca15.3
%K pain
%K overall survival
%K chemotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396668/